Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhijit Ray

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
European Journal of Pharmacology|July 6, 2007
Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit modelKrishna S Naruganahalli, Sandeep Sinha, Laxminarayan G Hegde, et al.
Journal of Receptor and Signal Transduction Research|March 17, 2009
Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometerSuman Gupta, Rakesh Kumar Singh, Kamna Nanda, et al.
Molecular Pharmacology|June 15, 2007
Dynamin 2 regulates riboflavin endocytosis in human placental trophoblastsAmy B Foraker, Abhijit Ray, Tatiana Claro Da Silva, et al.
Biochemical and Biophysical Research Communications|December 1, 2009
Comparative deacetylase activity of wild type and mutants of SIRT1Renu Malik, Akriti Kashyap, Karuna Bansal, et al.
Bioorganic & Medicinal Chemistry|February 5, 2004
11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicityAlexander L Ruchelman, Sudhir K Singh, Abhijit Ray, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
Diaza- and triazachrysenes: potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435Alexander L Ruchelman, Sudhir K Singh, Xiaohua Wu, et al.
Pharmacology|March 27, 2009
Pharmacology of a novel, orally active PDE4 inhibitorSunanda G Dastidar, Abhijit Ray, Rajkumar Shirumalla, et al.
Nanotoxicology|July 29, 2011
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticlesKhaled Greish, Giridhar Thiagarajan, Heather Herd, et al.
European Journal of Pharmacology|June 7, 2011
Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatmentRuchi Tandon, Shweta Kapoor, Shireen Vali, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2010
Synthesis and biological activity of N-substituted aminocarbonyl-1,3-dioxolanes as VLA-4 antagonistsAbdul Rehman, Ajay Soni, Keshav Naik, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
European Journal of Pharmacology|July 6, 2007
Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit modelKrishna S Naruganahalli, Sandeep Sinha, Laxminarayan G Hegde, et al.
Journal of Receptor and Signal Transduction Research|March 17, 2009
Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometerSuman Gupta, Rakesh Kumar Singh, Kamna Nanda, et al.
Molecular Pharmacology|June 15, 2007
Dynamin 2 regulates riboflavin endocytosis in human placental trophoblastsAmy B Foraker, Abhijit Ray, Tatiana Claro Da Silva, et al.
Biochemical and Biophysical Research Communications|December 1, 2009
Comparative deacetylase activity of wild type and mutants of SIRT1Renu Malik, Akriti Kashyap, Karuna Bansal, et al.
Bioorganic & Medicinal Chemistry|February 5, 2004
11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicityAlexander L Ruchelman, Sudhir K Singh, Abhijit Ray, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
Diaza- and triazachrysenes: potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435Alexander L Ruchelman, Sudhir K Singh, Xiaohua Wu, et al.
Pharmacology|March 27, 2009
Pharmacology of a novel, orally active PDE4 inhibitorSunanda G Dastidar, Abhijit Ray, Rajkumar Shirumalla, et al.
Nanotoxicology|July 29, 2011
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticlesKhaled Greish, Giridhar Thiagarajan, Heather Herd, et al.
European Journal of Pharmacology|June 7, 2011
Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatmentRuchi Tandon, Shweta Kapoor, Shireen Vali, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2010
Synthesis and biological activity of N-substituted aminocarbonyl-1,3-dioxolanes as VLA-4 antagonistsAbdul Rehman, Ajay Soni, Keshav Naik, et al.
Pageof 11